Learning Outcomes:
The learning objectives of the Advanced Cancer Biology and Pharmacology module should enable you to:
1. Describe the major environmental risk factors for impacting risk of cancer development.
2. Understand the use of (chemo)prevention strategies to reduce risk of cancer development.
3. Critically evaluate existing and novel therapeutic approaches to cancer chemotherapy.
4. Understand & describe how knowledge of cancer biology can inform development of targeted cancer therapies such as immunotherapies & therapy selection: Develop an appreciation of how omics technologies are facilitating this process.
5. Describe the core issues, molecular approaches, challenges and benefits of developing targeted cancer therapies.
6. Understand how knowledge of the tumour microenviroment, tumour heterogeneity and drug resistance mechanisms affect drug efficacy, and need to be more comprehensively considered in future drug development to improve cancer treatment.
7. Describe how cancer genomics is implemented in clinical routine and clinical trials.
8. Discuss how the gut microbiome can inform development of cancer therapies.
9. Appreciate how Systems Biology and Modelling of Signalling Networks helps us to understand complex biology and to design novel therapeutics.
10. Understand the concept of Personalised P4 medicine approaches to cancer detection and treatment, against the opposing concerns on O4 medicine (such as over-diagnosis, over-treatment).
Indicative Module Content:
Lecture Topics (Provisional list, subject to alteration):
1. Introduction to Module / Cancer Epidemiology and chemoprevention
2. Tumour heterogeneity and the tumour microenvironment (signalling in ME determines metastatic potential)
3. Molecular therapeutic targeting based on cancer biology / genomics; an overview
4. Advances in cancer treatment approaches based on Genomics
5. Pharmacogenetics in drug development / treatment
6. Cancer epigenetics biomarkers and drug development
7. Advances in cancer treatment approaches II (Cancer immunotherapy, digital pathology, single cell proteomics, liquid biopsies)
8. Focus on targeted therapies and mechanisms of drug resistance
9. Nanotechnology therapy in cancer
10. Emerging role of the microbiome in cancer prognosis and response to chemotherapy
11. Overview on systems medicine approaches for personalised medicine in cancer therapy
12. Student Hot Topics Presentations